Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Avadel Pharmaceuticals PLC (NASDAQ:AVDL)

8.78
Delayed Data
As of Aug 18
 +0.12 / +1.39%
Today’s Change
8.14
Today|||52-Week Range
15.45
-15.50%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$351.9M

Company Description

Avadel Pharmaceuticals Plc develops and manufactures pharmaceutical products. The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.

Contact Information

Avadel Pharmaceuticals Plc
Blanchardstown Corporate Park
Dublin Dublin 15
P:(347) 278-3434
Investor Relations:

Employees

Shareholders

Other institutional52.40%
Mutual fund holders16.34%
Individual stakeholders12.74%

Top Executives

Michael Shannon AndersonChief Executive Officer & Director
Michael F. KananCFO, Treasurer, Director & CAO
David MonteithVice President-Research & Development
Gregory J. DivisChief Commercial Officer & Executive VP
Phillandas T. ThompsonSecretary, Director, SVP & General Counsel